Back to Agenda
Session 11 Plenary: Roundtables and Closing Remarks
Session Chair(s)
Tamei Elliott, MS
Associate Director, Scientific Programs
DIA, United States
This final session is formatted as roundtable discussions for those involved in the clinical, pharmacovigilance, and regulatory functional areas. This interactive session will provide the opportunity for our program committee members and fellow attendees to dive deeper into the topics their industry is currently facing along with the topics of discussion from our previous sessions. Attendees will be able to raise the tough questions they’ve been facing in their everyday roles, share their experiences, and walk away with key learnings to share amongst their company or organization.
Have an account?